Replies to post #2174 on Vitro Diagnostics Inc (fka VODG)

[JonesBur]

Instead of this PR, I wish they would put their time towards getting their late 10Qs filed or actually expanding their production by five-fold instead of just stating what they said they would complete last year. Hopefully this year is a better year for them growth wise, but I'm still thinking the best shot here is through a partnership or acquisition, which I am glad they mentioned.

[Potse]

March 1 press release is interesting/encouraging.....

Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced increased revenues during its first fiscal quarter 2016 of 143% compared to the same period in 2015, predominately due to further increased sales of its cell lines and MSC-Gro™ Brand of cell culture media products.

VODG remains a pretty attractive investment at current price levels, in my opinion. If/when the company fully updates its SEC filings, that should significantly reduce some of the additional/unnecessary risk that is currently present in the stock.

The stock has a history of pretty intense/unexpected price movements. It looks like there are a number of interesting announcements/developments that could be working their way forward, so it wouldn't be surprising at all to see some type of explosive high-volume spike or sustained move into a higher trading range in calendar 2016.

The March 1 press release is an encouraging sign that VODG's revenues may be regaining some consistency/momentum.......

First 6 months of 2015: $39K
Second 6 months of 2015: $60K
First quarter of 2016: $39K